ID   DAF_CAVPO               Reviewed;         507 AA.
AC   Q60401; P97254; P97255; P97256; Q60402; Q60403; Q60404; Q60405; Q60406;
AC   Q9WTI9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   07-OCT-2020, entry version 106.
DE   RecName: Full=Complement decay-accelerating factor;
DE   AltName: CD_antigen=CD55;
DE   Flags: Precursor;
GN   Name=CD55; Synonyms=DAF;
OS   Cavia porcellus (Guinea pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Hystricomorpha; Caviidae;
OC   Cavia.
OX   NCBI_TaxID=10141;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], GPI-ANCHOR AT ALA-358 (ISOFORM
RP   3), AND ALTERNATIVE SPLICING.
RC   STRAIN=Hartley; TISSUE=Spleen;
RX   PubMed=7545710;
RA   Nonaka M., Miwa T., Okada N., Nonaka M., Okada H.;
RT   "Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated
RT   by alternative splicing.";
RL   J. Immunol. 155:3037-3048(1995).
CC   -!- FUNCTION: This protein recognizes C4b and C3b fragments that condense
CC       with cell-surface hydroxyl or amino groups when nascent C4b and C3b are
CC       locally generated during C4 and c3 activation. Interaction of daf with
CC       cell-associated C4b and C3b polypeptides interferes with their ability
CC       to catalyze the conversion of C2 and factor B to enzymatically active
CC       C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the
CC       amplification convertases of the complement cascade. Inhibits
CC       complement activation by destabilizing and preventing the formation of
CC       C3 and C5 convertases, which prevents complement damage.
CC       {ECO:0000250|UniProtKB:P08174}.
CC   -!- SUBUNIT: Monomer (major form) and non-disulfide-linked, covalent
CC       homodimer (minor form). Interacts with ADGRE5.
CC       {ECO:0000250|UniProtKB:P08174}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell membrane; Lipid-anchor, GPI-
CC       anchor.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q60401-1; Sequence=Displayed;
CC       Name=2; Synonyms=GDA-TCS;
CC         IsoId=Q60401-2; Sequence=VSP_001193, VSP_001194, VSP_001199;
CC       Name=3; Synonyms=GDAB-GPI;
CC         IsoId=Q60401-3; Sequence=VSP_001194, VSP_001195, VSP_001196,
CC                                  VSP_001197;
CC       Name=4; Synonyms=GDAB-SEC;
CC         IsoId=Q60401-4; Sequence=VSP_001194, VSP_001195, VSP_001196,
CC                                  VSP_001198;
CC       Name=5; Synonyms=GDAB-TCL;
CC         IsoId=Q60401-5; Sequence=VSP_001194, VSP_001196;
CC       Name=6; Synonyms=GDABC-TCL;
CC         IsoId=Q60401-6; Sequence=VSP_001196;
CC       Name=7; Synonyms=GDAB-TCS;
CC         IsoId=Q60401-7; Sequence=VSP_001194, VSP_001199;
CC   -!- TISSUE SPECIFICITY: All the isoforms are widely expressed. GPI and TCS
CC       are the major forms, whereas SEC is minor and TCL is only present in
CC       trace levels.
CC   -!- MISCELLANEOUS: [Isoform 2]: Has a shorter cytoplasmic region.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Secreted. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Has a longer cytoplasmic region.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 6]: Has a longer cytoplasmic region.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 7]: Has a shorter cytoplasmic region.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the receptors of complement activation (RCA)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D55667; BAA09514.1; -; Genomic_DNA.
DR   EMBL; D55667; BAA09515.1; -; Genomic_DNA.
DR   EMBL; D55667; BAA09516.1; -; Genomic_DNA.
DR   EMBL; D55667; BAA09517.1; -; Genomic_DNA.
DR   EMBL; D55667; BAA09518.1; -; Genomic_DNA.
DR   EMBL; D49416; BAA08396.1; -; mRNA.
DR   EMBL; D49417; BAA08397.1; -; mRNA.
DR   EMBL; D49418; BAA08398.1; -; mRNA.
DR   EMBL; D49419; BAA08399.1; -; mRNA.
DR   EMBL; D49420; BAA08400.1; -; mRNA.
DR   EMBL; D49421; BAA08401.1; -; mRNA.
DR   RefSeq; NP_001166351.1; NM_001172880.1. [Q60401-5]
DR   RefSeq; NP_001166352.1; NM_001172881.1. [Q60401-6]
DR   RefSeq; NP_001166353.1; NM_001172882.1.
DR   RefSeq; NP_001166354.1; NM_001172883.1. [Q60401-3]
DR   RefSeq; NP_001166355.1; NM_001172884.1.
DR   RefSeq; NP_001166356.1; NM_001172885.1.
DR   SMR; Q60401; -.
DR   GeneID; 100379575; -.
DR   CTD; 1604; -.
DR   InParanoid; Q60401; -.
DR   OrthoDB; 1101732at2759; -.
DR   Proteomes; UP000005447; Unassembled WGS sequence.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045916; P:negative regulation of complement activation; ISS:UniProtKB.
DR   CDD; cd00033; CCP; 4.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   Pfam; PF00084; Sushi; 4.
DR   SMART; SM00032; CCP; 4.
DR   SUPFAM; SSF57535; SSF57535; 4.
DR   PROSITE; PS50923; SUSHI; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complement pathway; Disulfide bond;
KW   Glycoprotein; GPI-anchor; Immunity; Innate immunity; Lipoprotein; Membrane;
KW   Reference proteome; Repeat; Secreted; Signal; Sushi.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..507
FT                   /note="Complement decay-accelerating factor"
FT                   /id="PRO_0000005997"
FT   DOMAIN          32..94
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          95..159
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          160..221
FT                   /note="Sushi 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          222..284
FT                   /note="Sushi 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   COMPBIAS        284..458
FT                   /note="Ser/Thr-rich"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        93
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        442
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        493
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..80
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        64..92
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        96..144
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        127..157
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        162..203
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        189..219
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        224..266
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        252..282
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   VAR_SEQ         302..334
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001193"
FT   VAR_SEQ         335..366
FT                   /note="Missing (in isoform 2, isoform 3, isoform 4, isoform
FT                   5 and isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001194"
FT   VAR_SEQ         399..424
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001195"
FT   VAR_SEQ         425..458
FT                   /note="Missing (in isoform 3, isoform 4, isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001196"
FT   VAR_SEQ         459..507
FT                   /note="THVYKVDSFACGASNHWLADIAKEDLRRDFSNAQNISSLLQVLGAAQTQ ->
FT                   ANMRHMRTKNPMLYVIT (in isoform 2 and isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001199"
FT   VAR_SEQ         459..507
FT                   /note="THVYKVDSFACGASNHWLADIAKEDLRRDFSNAQNISSLLQVLGAAQTQ ->
FT                   GHMCIKLTVLLVVLVIIG (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001197"
FT   VAR_SEQ         459..507
FT                   /note="THVYKVDSFACGASNHWLADIAKEDLRRDFSNAQNISSLLQVLGAAQTQ ->
FT                   DTCV (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001198"
FT   LIPID           Q60401-3:358
FT                   /note="GPI-anchor amidated alanine"
FT                   /evidence="ECO:0000305|PubMed:7545710"
SQ   SEQUENCE   507 AA;  55264 MW;  D25BBB7749425210 CRC64;
     MKRGRPAALR CLLLLRAPAL LLLLRAAAVQ GDCGPLPVVP RAHPASASAG STSFPENTTV
     LYTCDQGFVK IPGKPDAVVC ISSRWTDIEE FCNRSCEVPP RLPYAILKSA YISKNYFPVD
     TVVEYECRPG YRKKYPIQSG KITCRDDLTW STPAEFCEKK QCPNPGELVN GNINVTTDLL
     LGSQIFFSCD PGYRLTGEAS AFCMIKGNAV GWSSSLPTCI KIICPEPPQI ENGRIVNEED
     TYEYRHVVTY ECNKGFVLTG KSHISCIVRD DVGEWSDPPP TCRVKSPPVI PPQKPTTTSA
     PGTTTTLPTQ KPTTVNTAGP EVPTTQRSTT VNVPGTKVPT TQRSTTVNVP GTEVPTTWKS
     TTVNVPAAGN RPDTRTTIKS TTASEEKDLA SGYRTFLYGV GVGVPVIVCS LGLGVYWWIH
     RTSGQYETYE NKESNVICHN LNESDATSEI TSSDKLKKTH VYKVDSFACG ASNHWLADIA
     KEDLRRDFSN AQNISSLLQV LGAAQTQ
//
